Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Price (688076.SS)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

214,389,612

(0.5656)%

Income Statement Summary

Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Operating Income
Other Expenses
Net Income
news-img
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.
news-img

Income Statement

Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.

Currency: CNY

YEAR 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Revenue
Revenue 0.00

+0%

0.00

+0%

8,777,246.00

+0%

8,022,583.00

-9%

228,867,458.00

+2,753%

255,527,351.00

+12%

371,530,570.00

+45%

566,872,462.00

+53%

643,869,464.00

+14%

651,291,707.00

+1%

1,026,346,449.00

+58%

Cost of Revenue
Cost of Revenue 425,909.00 593,704.00 7,530,295.00 13,630,935.00 87,824,664.00 101,991,860.00 173,251,896.00 237,156,213.00 284,874,798.00 276,321,614.00 444,267,009.00
Gross Profit
Gross Profit -425,909.00

+0%

-593,704.00

+39%

1,246,951.00

-310%

-5,608,352.00

-550%

141,042,794.00

-2,615%

153,535,491.00

+9%

198,278,674.00

+29%

329,716,249.00

+66%

358,994,666.00

+9%

374,970,093.00

+4%

582,079,440.00

+55%

Gross Profit Ratio (0.00%) (0.00%) (0.14%) (-0.70%) (0.62%) (0.60%) (0.53%) (0.58%) (0.56%) (0.58%) (0.57%)
Operating Expenses
Research and Development 1,544,681.00 3,574,549.00 0.00 15,519,208.00 17,440,992.00 35,121,445.00 46,495,552.00 60,533,819.00 63,087,924.00 69,472,383.00 124,889,236.00
General and Administrative 14,016,582.00 20,371,445.00 26,169,847.00 71,486,279.00 12,904,092.00 19,762,892.00 29,107,980.00 39,789,761.00 58,257,882.00 53,143,351.00 76,335,342.00
Selling, General & Admin... 14,122,380.00 20,540,575.00 26,679,148.00 65,057,563.00 14,433,720.00 22,851,307.00 37,967,884.00 51,337,784.00 70,844,481.00 88,109,185.00 273,337,067.00
Selling & Marketing Exp... 105,798.00 169,129.00 509,300.00 853,112.00 1,529,628.00 3,088,414.00 8,859,903.00 11,548,022.00 12,586,598.00 34,965,834.00 42,063,795.00
Depreciation and Amortiz... 3,409,987.00 9,452,960.00 9,697,269.00 10,750,065.00 18,895,298.00 25,904,900.00 46,337,500.00 77,116,400.00 89,015,415.00 104,680,249.00 135,551,077.00
Other Expenses 2,861,027.00 735,563.00 203,491.00 -96,559.00 418,569.00 -95,199.69 51,826,262.00 47,636,725.00 80,210,501.00 97,958,214.00 1,388,972.00
Total Operating Expenses 14,122,380.00 20,540,575.00 26,679,148.00 65,154,123.00 73,278,274.00 111,997,599.00 136,289,699.00 159,508,328.00 214,142,907.00 255,539,783.00 399,615,275.00
Cost and Exponses 14,122,380.00 20,540,575.00 34,209,444.00 78,785,056.00 161,102,939.00 213,989,460.00 309,541,595.00 396,664,542.00 499,017,706.00 531,861,398.00 843,882,284.00
Operating Income
Operating Income -16,496,931.50

+0%

-25,892,707.91

+57%

-30,357,449.69

+17%

-70,762,480.00

+133%

56,595,259.00

-180%

31,435,650.00

-44%

67,809,228.00

+116%

143,815,401.00

+112%

128,313,239.00

-11%

124,851,517.00

-3%

189,665,794.00

+52%

Operating Income Ratio (0.00%) (0.00%) (-3.46%) (-8.82%) (0.25%) (0.12%) (0.18%) (0.25%) (0.20%) (0.19%) (0.18%)
Other Income and Exp...
Interest Income 0.00 0.00 0.00 4,544,316.00 192,772.00 440,939.00 600,030.00 736,821.00 5,294,340.00 8,576,656.00 5,871,166.00
Interest Expenses 0.00 0.00 0.00 0.00 6,714,958.00 9,387,978.00 7,160,708.00 11,631,662.00 6,118,270.00 9,263,199.00 16,085,329.00
Total Other Income/Exp... 2,861,027.00 735,563.00 203,491.00 -4,035,019.00 418,569.00 -95,200.00 -14,396,248.00 2,745,641.00 -2,581,892.00 -1,693,288.00 -16,538,921.00
EBITDA
EBITDA -10,800,502.00 -10,926,515.00 -15,734,928.24 -58,800,011.00 82,557,347.00 60,126,243.00 107,594,072.00 236,270,313.00 221,023,380.00 237,281,727.00 324,763,281.00
EBITDA ratio (0.00%) (0.00%) (-1.74%) (-7.48%) (0.38%) (0.26%) (0.29%) (0.43%) (0.36%) (0.38%) (0.32%)
Income Before Tax
Income Before Tax -13,635,903.59 -25,157,144.65 -30,153,958.24 -74,797,496.00 57,013,828.00 31,340,450.00 53,412,980.00 146,561,042.00 125,731,347.00 123,158,229.00 173,126,873.00
Income Before Tax Ratio (0.00%) (0.00%) (-3.44%) (-9.32%) (0.25%) (0.12%) (0.14%) (0.26%) (0.20%) (0.19%) (0.17%)
Income Tax Expense
Income Tax Expense 767,197.00 5,191,269.00 5,380,185.00 5.00 15,084,491.00 -13,340,726.16 8,607,030.00 26,533,146.00 16,923,178.00 387,707.00 7,674,212.00
Net Income
Net Income -13,635,903.59

+0%

-25,157,144.65

+84%

-30,153,958.24

+20%

-74,797,496.00

+148%

41,929,337.00

-156%

43,908,449.00

+5%

48,610,494.00

+11%

123,441,585.00

+154%

115,388,354.00

-7%

129,106,565.00

+12%

162,936,105.00

+26%

Net Income Ratio (0.00%) (0.00%) (-3.44%) (-9.32%) (0.18%) (0.17%) (0.13%) (0.22%) (0.18%) (0.20%) (0.16%)
Earning Per Share
Basic EPS -0.27 -0.50 -0.60 -0.35 0.37 0.32 0.23 0.58 0.54 0.61 0.76
Diluted EPS -0.27 -0.50 -0.60 -0.35 0.37 0.32 0.23 0.58 0.54 0.61 0.76
Share Outstanding
Basic Share Outstanding 50,503,329.00 50,314,282.00 50,256,595.00 213,183,800.00 113,322,533.00 137,213,905.00 213,183,800.00 213,183,800.00 213,183,800.00 213,183,800.00 214,389,612.00
Diluted Share Outstanding 50,503,329.00 50,314,289.00 50,256,597.00 213,183,800.00 113,322,533.00 137,213,905.00 213,183,800.00 213,183,800.00 213,183,800.00 213,183,800.00 214,389,612.00
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation